JP2011529936A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529936A5
JP2011529936A5 JP2011521529A JP2011521529A JP2011529936A5 JP 2011529936 A5 JP2011529936 A5 JP 2011529936A5 JP 2011521529 A JP2011521529 A JP 2011521529A JP 2011521529 A JP2011521529 A JP 2011521529A JP 2011529936 A5 JP2011529936 A5 JP 2011529936A5
Authority
JP
Japan
Prior art keywords
composition according
composition
dicarboxylic acid
chitosan
dicarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011521529A
Other languages
English (en)
Japanese (ja)
Other versions
JP5646477B2 (ja
JP2011529936A (ja
Filing date
Publication date
Priority claimed from EP08161799A external-priority patent/EP2116237A1/en
Application filed filed Critical
Publication of JP2011529936A publication Critical patent/JP2011529936A/ja
Publication of JP2011529936A5 publication Critical patent/JP2011529936A5/ja
Application granted granted Critical
Publication of JP5646477B2 publication Critical patent/JP5646477B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011521529A 2008-08-05 2009-07-28 キトサンおよびジカルボン酸を含む、酒さ疾患を治療するための組成物 Expired - Fee Related JP5646477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08161799.5 2008-08-05
EP08161799A EP2116237A1 (en) 2008-08-05 2008-08-05 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
PCT/EP2009/059749 WO2009150257A2 (en) 2008-08-05 2009-07-28 Compositions for treating rosacea

Publications (3)

Publication Number Publication Date
JP2011529936A JP2011529936A (ja) 2011-12-15
JP2011529936A5 true JP2011529936A5 (OSRAM) 2012-05-17
JP5646477B2 JP5646477B2 (ja) 2014-12-24

Family

ID=40140031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521529A Expired - Fee Related JP5646477B2 (ja) 2008-08-05 2009-07-28 キトサンおよびジカルボン酸を含む、酒さ疾患を治療するための組成物

Country Status (28)

Country Link
US (1) US9034845B2 (OSRAM)
EP (2) EP2116237A1 (OSRAM)
JP (1) JP5646477B2 (OSRAM)
KR (1) KR101623375B1 (OSRAM)
CN (1) CN102105142B (OSRAM)
AR (1) AR072917A1 (OSRAM)
AU (1) AU2009256524B2 (OSRAM)
BR (1) BRPI0917584B8 (OSRAM)
CA (1) CA2731138C (OSRAM)
CL (1) CL2011000174A1 (OSRAM)
CY (1) CY1118256T1 (OSRAM)
DK (1) DK2306999T3 (OSRAM)
EA (1) EA020417B1 (OSRAM)
ES (1) ES2606233T3 (OSRAM)
HR (1) HRP20161594T1 (OSRAM)
HU (1) HUE031171T2 (OSRAM)
IL (1) IL210695A (OSRAM)
LT (1) LT2306999T (OSRAM)
MX (1) MX2011001369A (OSRAM)
NZ (1) NZ590800A (OSRAM)
PE (1) PE20110564A1 (OSRAM)
PL (1) PL2306999T3 (OSRAM)
PT (1) PT2306999T (OSRAM)
RS (1) RS55507B1 (OSRAM)
SI (1) SI2306999T1 (OSRAM)
SM (1) SMT201600403B (OSRAM)
WO (1) WO2009150257A2 (OSRAM)
ZA (1) ZA201100350B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2975004B1 (fr) 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
EP3233027B1 (en) 2014-12-15 2021-10-13 Unilever IP Holdings B.V. Compositions for providing improved sunscreen protection
GB2600384A (en) 2020-09-30 2022-05-04 Vaderis Therapeutics Ag Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845204A (en) * 1985-02-07 1989-07-04 Wella Aktiengesellschaft Cosmetic compositions on the basis of alkyl-hydroxypropyl-substituted chitosan derivatives, new chitosan derivatives and processes for the production thereof
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
JPH05339152A (ja) * 1992-06-09 1993-12-21 Nippon Soda Co Ltd 皮膚病変局所投与薬剤含有キトサン誘導体フィルム剤
DE69424100T2 (de) * 1993-08-10 2000-10-12 Kao Corp Organopolysiloxane und ein Verfahren zum Haarfestigen unter Verwendung derselben
JP2001512471A (ja) * 1997-02-21 2001-08-21 バイヤースドルフ・アクチエンゲゼルシヤフト しゅさの処置のための調製物
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
US6734210B2 (en) * 2000-02-24 2004-05-11 Rolland F. Hebert Therapeutically improved salts of azelaic acid
US6451773B1 (en) * 2000-03-31 2002-09-17 Cognis Corporation Chitosan formulation with azelaic acid and other actives for the treatment of acne
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
US6680062B2 (en) * 2001-10-05 2004-01-20 Color Access, Inc. Anti-irritating rosacea treatment
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20040081672A1 (en) 2002-10-25 2004-04-29 Gupta Shyam K. Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
CN1816287A (zh) * 2003-01-31 2006-08-09 宝洁公司 改善哺乳动物角质组织外观的方法
US20040156873A1 (en) * 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
EP1491202A1 (en) 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US7416525B2 (en) * 2003-09-18 2008-08-26 Myrakelle, Llc Rotary blood pump
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
EP1600158A1 (en) * 2004-05-26 2005-11-30 Galderma Research & Development, S.N.C. Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
US20060024339A1 (en) * 2004-07-29 2006-02-02 Howard Murad Methods of managing the redness associated with a dermatological condition
ITMI20041567A1 (it) * 2004-07-30 2004-10-30 Maycos Italiana Di Comini Miro "derivati n-acilati di acidi bicarbossilici con amminoacidi e con idrolizzati proteici vegetali e loro applicazione in prodotti cosmetici, dermofarmaceutici e farmaceutici"
CN1813664A (zh) * 2005-11-24 2006-08-09 曾能 一种水凝胶美容护肤贴和精华护肤液的制造工艺及产品
TWI367109B (en) * 2006-01-19 2012-07-01 Mary Kay Inc Compositions comprising kakadu plum extract or acai berry extract
JP4866173B2 (ja) * 2006-01-25 2012-02-01 大日精化工業株式会社 ヒドロキシアルキル化キトサン溶液
WO2007149868A2 (en) * 2006-06-20 2007-12-27 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
WO2008038147A2 (en) * 2006-07-05 2008-04-03 Foamix Ltd. Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin

Similar Documents

Publication Publication Date Title
JP2008543854A5 (OSRAM)
JP2008509166A5 (OSRAM)
JP2011529936A5 (OSRAM)
JP2010077141A5 (OSRAM)
RU2007119380A (ru) Косметические продукты, предназначенные для ухода за собой, включающие соли дигидроксипропилтри (c1-c3алкил) аммония
RU2017120177A (ru) Производные аминокислот и их использование
MA31801B1 (fr) Derives de 1,2,3-triazole destines a etre utilises comme inhibiteurs de la stearoyl-coa desaturase
JP2009544665A5 (OSRAM)
EP4293009A3 (en) Fenfluramine compositions and methods of preparing the same
JP2013518056A5 (OSRAM)
JP2012144490A (ja) 外用組成物
JP2011503167A5 (OSRAM)
SE0402762D0 (sv) Indazole sulphonamide derivatives
MX2009011554A (es) Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
MX2011013648A (es) Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos.
FI3817751T3 (fi) Vedettömän natriumtiosulfaatin formulaatioita
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2012508256A5 (OSRAM)
CY1116274T1 (el) Παραγωγο τριαζολιου για χρηση στη θεραπεια του νευροπαθητικου πονου και της ινομυαλγιας
JP2017516770A5 (OSRAM)
RU2008110644A (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
JP2014517848A5 (OSRAM)
SA520411881B1 (ar) صياغات إطلاق مديد لتطبيقات داخل المفصل
HRP20161594T1 (hr) Pripravci za liječenje rozaceje koji sadrže kitozan i amid dikarboksilne kiseline
JP2004534073A5 (OSRAM)